The roles of transforming growth factor-β 1 and vascular endothelial growth factor in the tracheal granulation formation

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2011, Pages 23-31

  Lee, Yu Chin ^a,b   Hung, Ming Hui ^a   Liu, Lung Yu ^a   Chang, Kuo Ting ^a   Chou, Tec Ying ^a,b   Wang, Yi Chung ^a   Wu, Yu Chung ^a,b   Lai, Chun Liang ^c,d   Tsai, Cheng Chien ^a   Su, Kang Cheng ^a   Perng, Diahn Warng ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Airway stenosis; Fibroblast; TGF 1; Tracheal granulation; VEGF

Indexed keywords

DEXAMETHASONE; ERYTHROMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 3; RECOMBINANT VASCULOTROPIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UO 126; VASCULOTROPIN; VIMENTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; FEMALE; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRACHEA GRANULATION; TRACHEA MUCOSA; TRACHEA STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GRANULATION TISSUE; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; SMAD3 PROTEIN; TRACHEA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIMENTIN;

EID: 79251599786     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.10.016     Document Type: Article

References (33)

1. Law J.H., Barnhart K., Rowlett W., de la Rocha O., Lowenberg S. Increased frequency of obstructive airway abnormalities with long-term tracheostomy. Chest 1993, 104:136-138.
2. Liu H., Chen J.C., Holinger L.D., Gonzalez-Crussi F. Histopathologic fundamentals of acquired laryngeal stenosis. Pediatr Pathol Lab Med 1995, 15:655-677.
3. Pokharel R.P., Maeda K., Yamamoto T., Noguchi K., Iwai Y., Nakamura H., et al. Expression of vascular endothelial growth factor in exuberant tracheal granulation tissue in children. J Pathol 1999, 188:82-86.
4. Tschumperlin D.J., Shively J.D., Kikuchi T., Drazen J.M. Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. Am J Respir Cell Mol Biol 2003, 28:142-149.
5. Ressler B., Lee R.T., Randell S.H., Drazen J.M., Kamm R.D. Molecular responses of rat tracheal epithelial cells to transmembrane pressure. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1264-L1272.
6. Yamamoto H., Teramoto H., Uetani K., Igawa K., Shimizu E. Cyclic stretch upregulates interleukin-8 and transforming growth factor-beta1 production through a protein kinase C-dependent pathway in alveolar epithelial cells. Respirology 2002, 7:103-109.
7. Karagiannidis C., Velehorschi V., Obertrifter B., Macha H.N., Linder A., Freitag L. High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest 2006, 129:1298-1304.
8. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342:1350-1358.
9. Leask A., Abraham D.J. TGF-beta signaling and the fibrotic response. Faseb J 2004, 18:816-827.
10. Wen F.Q., Liu X., Manda W., Terasaki Y., Kobayashi T., Abe S., et al. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J Allergy Clin Immunol 2003, 111:1307-1318.
11. Voelkel N.F., Vandivier R.W., Tuder R.M. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006, 290:L209-L221.
12. Jinnin M., Ihn H., Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol 2006, 69:597-607.
13. Balestrieri F., Watson C.B. Intubation granuloma. Otolaryngol Clin North Am 1982, 15:567-579.
14. Adamson I.Y., Young L., Bowden D.H. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988, 130:377-383.
15. Dai J., Gilks B., Price K., Churg A. Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am J Respir Crit Care Med 1998, 158:1907-1913.
16. Grillo H.C. Stents and sense. Ann Thorac Surg 2000, 70:1142.
17. Hannigan M., Zhan L., Ai Y., Huang C.K. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 1998, 246:55-58.
18. Postlethwaite A.E., Keski-Oja J., Moses H.L., Kang A.H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987, 165:251-256.
19. Perng D.W., Wu Y.C., Chang K.T., Wu M.T., Chiou Y.C., Su K.C., et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 2006, 34:101-107.
20. Horiba K., Fukuda Y. Synchronous appearance of fibronectin, integrin alpha 5 beta 1, vinculin and actin in epithelial cells and fibroblasts during rat tracheal wound healing. Virchows Arch 1994, 425:425-434.
21. Coultas L., Chawengsaksophak K., Rossant J. Endothelial cells and VEGF in vascular development. Nature 2005, 438:937-945.
22. Savona C., Javerzat S., Perollet C., Bikfalvi A. [Angiogenesis and neoangiogenesis]. Rev Prat 1997, 47:2239-2243.
23. Kano M.R., Morishita Y., Iwata C., Iwasaka S., Watabe T., Ouchi Y., et al. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005, 118:3759-3768.
24. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000, 55:15-35. discussion 35-16.
25. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
26. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647.
27. Brenner R.E., Felger D., Winter C., Christiansen A., Hofmann D., Bartmann P. Effects of dexamethasone on proliferation, chemotaxis, collagen I, and fibronectin-metabolism of human fetal lung fibroblasts. Pediatr Pulmonol 2001, 32:1-7.
28. Sabatini F., Silvestri M., Sale R., Serpero L., Giuliani M., Scarso L., et al. Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. Pulm Pharmacol Ther 2003, 16:287-297.
29. Azuma A., Furuta T., Enomoto T., Hashimoto Y., Uematsu K., Nukariya N., et al. Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. Thorax 1998, 53:186-189.
30. Li Y., Azuma A., Takahashi S., Usuki J., Matsuda K., Aoyama A., et al. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest 2002, 122:2137-2145.
31. Yu C., Azuma A., Li Y., Wang C., Abe S., Usuki J., et al. EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts. Exp Lung Res 2008, 34:343-354.
32. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993, 147:153-159.
33. Amsden G.W. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?. J Antimicrob Chemother 2005, 55:10-21.